Of note, BRCA1 mutation c.3578_3759delCT has been previously described by our group in an unrelated patient [21], although this patient had breast cancer diagnosed at 31 years; BRCA2 mutation c.7805+2_7805+3delTA has also been already described [13] but is included now as belonging to an ovary cancer patient. This evidence concerns the gene BRCA2 and ovarian cancer.